×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Pharmacovigilance

Pharmacovigilance Services & Patient Safety Solutions

Global Clinical and Post Market Safety and Pharmacovigilance Services for Pharmaceutical and Biotech Industry

Why Artixio For Your Pharmacovigilance Solutions?

In ever evolving, dynamic global regulatory environment, patient safety through effective Pharamacovigilance (PV) is critical for manufacturers. Artixio offers a range of Pharmacovigilance (PV) services across pharmaceutical and biotech product clinical development and post-marketing helping our clients achieve excellence in patient safety. Our cross functional team covers comprehensive range of services across PV value chain.

Post Market Surveillance → Safety Surveillance → Allied Safety Activities

Literature Management

Intake Services

AE Case Processing

Product Complaint Management

Medical Writing

Signal Management

Risk Management

Audit & Inspection Support

Safety Data Exchange Agreement

QPPV Office

Affiliate Support

Technology Services

Elevate Global Patient Safety through Artixio’s Hybrid (Centralized and Regional) Pharmacovigilance Services

Our 100+ Pharmacovigilance experts based centrally and regional countries across 70+ key global markets have helped thousands of biotech and pharmaceutical companies successfully maintain safety using proven best practices. Coupled with Artixio’s intelligence-based services platform, Dvarka, innovators and manufacturers from around the world have benefited by managing the pharmacovigilance strategy seamlessly across the clinical development and post market surveillance.

Pharmacovigilance for Global Markets

Driven by key regional regulatory and market insights, Artixio enables seamless product compliance monitoring and patient safety through proactive pharmacovigilance strategies.

Efficient Centralized Solutions

Hybrid model for centralized, high quality safety services that drive efficiency and cost effectiveness combined with regional pharmacovigilance expertise to manage large scale global operations.

Regulatory Excellence in Every Step

At Artixio, we bring insights from successful regulatory approvals and hands-on experience across various markets and product categories. By combining regulatory best practices with practical know-how, we deliver reliable and efficient solutions that support your compliance goals with confidence.

Why Artixio For Pharmacovigilance Services?

FAQs

1. What are key components of global pharmacovigilance?

Global phramacovigilance encompass a variety of activities, including regulatory intelligence and strategy for pharmacovigilance implementation, maintenance and monitoring. Pharmacoviglance includes combination of centralized and regional PV activities such as CIOMS Reporting on ADRs, Case Processing, Literature Review, PSUR Submission, RMP Submission, Local QPPV or safety responsible person, Local PSMF, Distribution of Direct Healthcare Professional letters, Review Labeling and Artwork among others.

Artixio uses hub and spoke model using a centralized pharmacovigilance team including Project Managers, PV Managers, PV specialists, Medical Reviewers to support activities across literature review, case processing, medical review and report authoring and submissions. The central team works closely with regional PV specialists and Qualified Responsible Persons for PV to ensure product safety and compliance in international markets. Regional submissions are performed by Artixio’s regional team members including continuous LQPPV activities such as Acting as a local contact point for Local Health Authority and Qualified Person for Pharmacovigilance & Deputy of QPPV, •Handling Local Health Authority Requests, sending monthly reports, where required by local legislation, ongoing documentation of LQPPV activities and ADR Monitoring.
Few challenges that companies face while managing global pharmacovigilance include, but not limited to, lack of knowledge of local regulations related to pharmacovigilance, post market surveillance and products safety, lack of experience, regional language and cultural nuances, lack of trusted expert with global perspective, irregular processes, inconsistency in documents, requirements for part-time pharmacoviglance experts for managing small portfolio of products, requirement for a Local Qualified Person responsible for PV (LQPPV) intellectual property security, quality of documentation, transparency, maintaining compliance with changing regulations, products portfolio revenue versus cost of compliance/ ROI and others.
Artixio addresses these challenges by providing flexible, budget friendly and timely pharmacovigilance services including LQPPV using global standards for seamless projects delivery, secure information exchange, high quality services, regional expertise and network and systems driven processes.

Artixio has internal regulatory intelligence platform, Dvarka, that tracks global regulatory changes related to pharmacovigilance. The platform hosts,

  • Current regulations, directives, regulatory insights
  • Track changes in regulations, new guidelines, notifications from health authorities worldwide related to pharmacovigilance, post market surveillance and products safety
  • Insights by our Regional Regulatory Experts from their experience, attendance to Conference, Seminars, Trade Shows, HA Organized Trainings and Events
  • Artixio’s expert opinions and Case Studies

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Pharmacovigilance
Services Across Multiple Industries

Regulatory and compliance expert – Artixio

Pharmaceuticals

Medical device regulatory services – Artixio

MedTech

Cosmetics regulatory consulting – Artixio

Cosmetics

Nutrition regulatory consulting – Artixio

Nutrition

Biologics regulatory consulting – Artixio

Biologics

Veterinary regulatory consulting – Artixio

Veterinary

Expert Regulatory Services To Streamline Compliance

GxP Compliance Regulatory monitoring services
Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India Artixio – Regulatory affairs consulting expert

India

Singapore Artixio – Regulatory affairs consulting expert

Singapore

Mexico Artixio – Regulatory affairs consulting expert

Mexico

Brazil Artixio – Regulatory affairs consulting expert

Brazil

Vietnam Artixio – Regulatory affairs consulting expert

Vietnam

Malaysia Artixio – Regulatory affairs consulting expert

Malaysia

Argentina Artixio – Regulatory affairs consulting expert

Argentina

Colombia Artixio – Regulatory affairs consulting expert

Colombia

Taiwan Artixio – Regulatory affairs consulting expert

Taiwan

China Artixio – Regulatory affairs consulting expert

China

Europe Artixio – Regulatory affairs consulting expert

European

Thailand Artixio – Regulatory affairs consulting expert

Thailand

Indonesia Artixio – Regulatory affairs consulting expert

Indonesia

Philippines Artixio – Regulatory affairs consulting expert

Philippines

USA Artixio – Regulatory affairs consulting expert

USA

Japan Artixio – Regulatory affairs consulting expert

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

HSA Guidance on Class 2 CTGTP Registration in Singapore

HSA Guidance on Class

Advanced medicines, such as cell, gene, and tissue-engineered therapies, are revolutionizing modern medicine. In...

February 24, 2026
HSA Singapore Investigational Product Management Guidance

HSA Singapore Investigational Product

For locally registered products in Singapore, the management of investigational product (IP) for clinical...

February 23, 2026
Strategic Criteria for Selecting a Regulatory Consultant in Thailand

Strategic Criteria for Selecting

All industries in Thailand, including cosmetics, food, medical devices, and nutrition, develop very fast,...

January 28, 2026

Get in touch

×